Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 25, 2021
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
Tue, August 24, 2021
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
Marc Frahm Downgraded (TBPH) to Hold and Decreased Target to $14 on, Aug 24th, 2021
Marc Frahm of Cowen & Co., Downgraded "Theravance Biopharma, Inc." (TBPH) to Hold and Decreased Target from $42 to $14 on, Aug 24th, 2021.
Marc has made no other calls on TBPH in the last 4 months.
There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Marc's Rating of Hold.
This is the rating of the analyst that currently disagrees with Marc
- Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $27 on, Friday, July 16th, 2021
